Cleonice et al. reported that the expression of TLR2, TLR4 and TLR9 was significantly higher on CD4+ and CD8+ T lymphocytes from multiple sclerosis (MS) patients than on those from healthy individuals. This evidence concerns the gene TLR9 and myeloid sarcoma.